Review

Toward precision medicine: can neuroimaging prospectively predict early treatment outcomes in schizophrenia spectrum disorders? A systematic review and meta-analysis.

Claudio Caiazza Giancarlo Fusco L. Ugga Flavia Rossano C. Toni Mario Cirillo G. Sampogna Andrea Fiorillo

Sep 2026 · European Archives of Psychiatry and Clinical Neuroscience · 0 citations · 47 references

Medicine

TL;DR

Baseline neuroimaging may provide relevant prognostic information in Schizophrenia Spectrum, support that treatment response may be related to disturbances in large-scale network organization than to isolated structural abnormalities, and support the potential of prognostic neuroimaging in precision psychiatry and early-risk stratification.

DOI PubMed Semantic Scholar

View source

Similar papers

Review Open access Sep 2026

Pharmacogenomics and Neuroimaging for Predicting Treatment Response and Relapse in Co-Occurring Mental Illness and Substance Use Disorders: A Systematic Evidence Review

Background: Co-occurring mental illness and substance use disorders (SUDs) are associated with high clinical complexity, heterogeneous treatment response and recurrent relapse. Pharmacogenomic and neuroimaging biomarkers may complement conventional clinical predictors, but the extent to which evidence directly supports...

O. Akujuobi, J. Azu, S. O. Uzoigwe et al. · International Neuropsychiatr... · 0 citations

Review Open access Sep 2026

Diagnostic accuracy of circulating blood biomarker families in acute ischemic stroke: a secondary grouped meta-analysis with primary-study verification

Circulating biomarkers may complement clinical assessment and neuroimaging during the early evaluation of suspected acute ischemic stroke (AIS), but the evidence spans biologically and analytically heterogeneous test families. We revised the original analysis as a transparent secondary grouped diagnostic accuracy m...

Xiao Luo, Long-Feng Ran, Ya-Ou Wu et al. · Frontiers in Neurology · 0 citations

Open access Sep 2026

580. Clinical treatment pathways of antipsychotics in patients with schizophrenia spectrum disorder: a retrospective longitudinal observational study

This analysis of antipsychotic prescribing for first-episode SSD from 2014-2019 found quetiapine, olanzapine, aripiprazole, risperidone, and amisulpride were the most common initial agents, and the shift toward quetiapine aligns with international trends.

Q. Bo, T. Li, Y. Wang et al. · International Journal of Neu... · 0 citations

Open access Aug 2026

Dissecting multimodal predictors of psychosis risk and remission in youth at ultra‑high risk of developing psychosis: An exploratory study

Early identification of individuals at risk of developing psychosis enables timely intervention and better clinical outcomes. Current approach relies on clinical assessments, such as the Comprehensive Assessment for At‑Risk Mental States (CAARMS), which provides an Ultra‑High‑Risk (UHR) classification but have limited...

Weijia Kong, S. Tan, Matheus Calvin Lokadjaja et al. · PLOS mental health · 0 citations

Review Open access Aug 2026

Individualized Medication Selection and Outcome Prediction for Patients With Dementia and BPSD Based on Systemic Immune-Inflammation Index (SII): A Retrospective Case-Control Study

Background: Behavioural and psychological symptoms of dementia (BPSD) are often treated with atypical antipsychotics, but heterogeneous treatment responses remain a clinical challenge. A systemic inflammatory state may contribute to this heterogeneity, but it is unclear whether the baseline systemic immune-inflammation...

Jiawen Liu, Hao-Shui Hua, Qicheng Zhang et al. · Actas espanolas de psiquiatr... · 0 citations

Review Open access Sep 2026

Mild behavioral impairment and risk of incident dementia: A systematic review and meta-analysis

This systematic review evaluated longitudinal evidence on the association between MBI and incident dementia, including conversion rates, dementia subtypes, domain-specific risk patterns, and biomarker correlates, finding MBI seems to represent a clinically meaningful syndrome that identifies individuals at elevated ris...

K. L. M. Sassi, Anika Thomson, Vanessa M. Young et al. · Journal of Alzheimer's Disea... · 0 citations